The collection includes articles from BSAVA’s Companion magazine, webinars, and Congress lectures, covering topics such as ‘What does environmentally-friendly look like in practice?’, ‘20x20 visions of a greener future now’, and ‘One Health, One Planet: Why sustainability is a necessity’.
The collection builds on the work of the BSAVA Sustainability Working Group (SWG), which was formed to help small animal practices on their sustainability journey.
Carl Gorman, Junior Vice President of the BSAVA and Chair of the SWG said: “We are pleased to have created this collection of resources for veterinary professionals.
"It is increasingly important that we ensure sustainable working in small animal practice, and we hope that this collection highlights some of the ways in which staff can really make a difference in their practice”.
The collection is freely available in the BSAVA Library throughout December from: https://www.bsavalibrary.com/content/sustainability-in-practice
To find out more about the BSAVA SWG’s work, visit: https://www.bsava.com/aboutus/sustainability
For the project, the company has developed a Brachycephalic Obstructive Airway Syndrome (BOAS) clinical assessment tool which can be used by a vet or nurse in practice to make a diagnosis.
The assessment is a holistic one which includes taking a history of the animal, a full physical examination, an exercise test and an examination of the dog’s nostrils.
The results of the assessment are then discussed with the owner to agree on a course of treatment.
During each consultation, vets and nurses also look to talk sensitively with clients about breeding, buying and owning brachycephalic dog breeds, offering welfare advice on how to manage their dog’s lifestyle, including issues such as keeping their weight low and looking after them in hot weather.
CVS says it hopes this will increase a general level of welfare awareness amongst brachycephalic dog owners.
CVS has also created a collection of resources for its teams, including new clinical frameworks and veterinary guidelines, webinars and a CPD day on the subject.
The company has also created materials to help vets and nurses have what can be challenging discussions with clients, including consultation room posters and practice reception TV videos which showing the physiology of the brachycephalic breed.
CVS says that since launch in July last year, the 25 participating practices have conducted nearly 900 brachycephalic assessments, and it aims to have at least 5% of Pugs, French Bulldogs and Bulldogs undergoing assessment across its small animal division by 2028.
CPC, the pet crematorium, has developed a new online survey tool to help practice staff analyse the effectiveness of their bereavement care capabilities.
Called "Bereavement Care - How does your practice compare?", the online survey comprises a series of multiple choice questions designed to produce a star rating out of 5. The idea is that these questions will help practices establish whether they need to improve how staff deal with bereaved pet owners.
Duncan Francis, Director, CPC said: "Coping with the loss of a much-loved pet is never easy for a bereaved owner. While support from those who are close to both the owner and the pet can make a real difference, many vets and vet nurses have received little training on this sensitive topic.
"Understanding client's needs before, during and after euthanasia, helps staff establish a rapport with emotional clients at a critical time and maintains a positive practice image.
"The aim of the survey is to raise awareness among vets and vet nurses of the importance of feeling confident in their ability to help bereaved owners through their grief. This helps clients come to terms with the death of their pet enabling them to move on and welcome another companion animal into their lives."
To find out more about how CPC can help your practice to improve its bereavement care, please ring 01763 207700, email info@cpccares.com or visit www.cpcvets.com
Designed for the whole practice team, the Congress theme will be Smarter Working – better outcomes: focussing on how individual and veterinary practice life can be transformed through consistent incremental gains.
Congress will be opened by Cath Bishop (pictured), Olympic rower turned business coach, with an insight into how working smarter revolutionised her rowing career, and the importance of continued learning to help achieve the marginal gains required to help thrive in practice.
The Smarter Working non-clinical lecture and workshop programme will incorporate the following streams:
Saturday workshops are also included in the full congress ticket price.
The social programme includes an afternoon Happy Hour in the exhibition hall, a networking event and the President’s Party with a reception, three course meal and party band.
There will also be a commercial exhibition.
www.spvs-congress.co.uk
The Feline Advisory Bureau (FAB) has teamed up with Agria Pet Insurance to provide insurance cover for cats in the UK, with each policy generating a donation to the work of FAB and its International Fund for Cat Welfare.
Ross Tiffin, FAB's Strategy and Business Adviser said: 'In Agria, we have found a respected company that shares our ethos - it believes in sharing information to makes cats' lives better. One of the leading pet insurers in the world, Agria has been insuring pets since 1890 and has shared information on longevity and disease patterns with university researchers for many years.'
Claire Bessant, Chief Executive of FAB said: 'FAB has always been an enthusiastic supporter of health insurance for cats - we want cats to receive the best treatment without owners having to worry about the cost. Our support has now taken on a practical form in the shape of a general pet insurance guide and, through working closely with Agria, by providing cat owners with an excellent insurance option.'
To view A fabcats guide to cat insurance go to www.fabcats.org/catinsurance. The guide gives generic advice on choosing insurance.
For more information on Fabcats Cat Insurance from Agria go to www.fabcats.org/catinsurance or call Agria on 0800 369 9441.
Protexin Veterinary has launched CystoPro, a new product to aid in the management of urinary tract infections in dogs.
According to the company, the key active ingredients in the new product are proanthocyanidins (Type A PACs), derived from cranberries, which work by reducing the ability of E.coli bacteria to infect a dog's urinary tract.
In addition, CystoPro contains the probiotic Enterococcus faecium (NCIMB 10415) E1707 which Protexin says reduces pathogenic bacteria within the gastrointestinal tract thereby lessening the risk of ascending UTIs of faecal origin.
The product also contains Mannan-oligosaccharide (MOS), which Protexin claims binds E.coli and upregulates the innate immune system by attracting phagocytes to opsonise the bacteria.
Lastly CystoPro contains N-acetyl D-glucosamine which is said to reinforce the structure of the Glycosaminoglycan (GAG) layer that lines and protects the bladder urothelium.
CystoPro is available in boxes of 30 and 120 capsules.
Veterinary surgeons can consider a wider range of options when it comes to neutering cats and dogs. This was the message from veterinary reproduction specialist Angelika von Heimendahl MSc BVM(Berlin) MRCVS DipECAR, at a recent seminar on reproductive health organised by Virbac.
Mrs von Heimendahl, who runs the Cambridge based referral centre, Veterinary Reproduction Service, said: "Globally the approach to neutering varies hugely. Although neutering is considered as part of responsible pet ownership in the UK and performed routinely in every practice in the country, at the other end of the scale, in Germany and Scandinavia for example, this is considered mutilation and is prohibited by law.
"Despite the very low neutering rates - Norway 7% compared to UK around 80% - in these countries they do not have a problem with stray dogs, indicating that there are other factors such as education and attitudes to dog ownership that play a major role."
She added: "In other continental countries, bitch spaying is usually by ovariectomy rather than ovariohysterectomy.
"Some practices are now successfully offering clients a range of options, including medical castration, especially with new reproduction drugs recently introduced onto the market. The non-surgical contraceptive slow-release implant, deslorelin (Suprelorin), a GnRH superagonist lasts for six months, making medical castration a more practical solution for many owners."
Mrs Von Heimendahl also suggested that deslorelin, although off-licence, can be used in bitches as an alternative to spaying: "Whilst neutering can have advantages in terms of reduced incidence of certain cancers, there are also advantages of retaining both male and female dogs intact. Some cancers are less likely to occur in intact animals, for example there is a reduced risk of transitional cell carcinomas, haemangiosarcomas and osteosarcomas. Obesity and its associated problems are also less of an issue, which is a particular benefit for owners where the necessary reduced calorie intake post neutering is difficult to achieve."
Chris Taylor MRCVS, technical director of seminar organiser, Virbac, added that medical castration can offer dog owners the opportunity to 'test run' neutering of their animal, and pointed out that this is particularly useful for behavioural issues in young male dogs: "Twice yearly implants offer a practical alternative for clients, whether as a short or longer-term solution. As a solution focussed business, we are constantly striving to put forward a choice of options which can only have benefits for client and practice alike."
The BSAVA has announced Richard Dawkins as its headline speaker at BSAVA Congress 2013 next April.
Richard follows in the footsteps of Lord Robert Winston and Susan Greenfield as the special speaker for the BSAVA lecture.
The talk, sponsored by Anistel, takes place on the Thursday afternoon of in Hall 1 and is open to all Congress delegates.
Dawkins is a prolific writer who first came to prominence with his 1976 book The Selfish Gene, his strident manifesto for secularism. However it is The God Delusion that now finds him so frequently called upon for comment. Along with Stephen Hawkins, he is one of the few scientists that members of the public can easily identify, in part due to his willingness to engage in academic and media debates.
Dawkins was born in Nairobi in 1941 where his father worked for British colonial service. He returned to Britain after the war to grow up on the family's estate farm. He studied zoology at Balliol College, Oxford, where he was tutored by Nobel Prize-winning ethologist Nikolaas Tinbergen, graduating in 1962. He received his M.A. and D.Phil. degrees by 1966, and remained a research assistant for another year, when his research concerned models of animal decision-making.
He has since been an assistant professor of zoology at the University of California, Berkeley, and a lecturer and reader in zoology at University of Oxford. In 1995 he was appointed Simonyi Professor for the Public Understanding of Science, a position that had been endowed by Charles Simonyi with the express intention that the holder "be expected to make important contributions to the public understanding of some scientific field", and that its first holder should be Richard Dawkins.
Image courtesy Zoe Margolis
Oxyglobin, Dechra’s unique haemoglobin-based oxygen carrying fluid for the treatment of anaemia in dogs, is now readily available in the UK.
“Over the past year, demand for this leading product has outstripped our limited supply from the manufacturer Biopure®,” explains Carol Morgan, product manager at Dechra Veterinary Products. “Production and supply issues in the US have now been resolved which means we can assure the future supply of Oxyglobin via the wholesaler to practices.”
Dechra is the sole distributor of Oxyglobin in the UK. The product requires no typing or cross matching and ensures no transfusion reactions or disease transmissions. “Its effectiveness can be measured by a rapid improvement in clinical signs, increased plasma haemoglobin concentration and arterial oxygen content. Oxyglobin has certainly proved itself as a valuable product to have in any practice,” adds Carol Morgan.
Oxyglobin can be stored at room temperature and has a shelf life of three years. For further details, please contact your local territory manager or phone Dechra on 01743 441 632.
Bayer has unveiled a major TV marketing campaign to promote Drontal.
An advertising campaign featuring the Drontal Schnauzer will run for two months. In addition, the company is sponsoring the TV series The Dog Whisperer, which is due to be aired from October to December this year.
The company is also launching a competition to enable owners to show off their pets and win a number of prizes. They include appearing in a double page spread in Your Dog and Your Cat magazines, holidays at pet-friendly hotels, digital cameras, shopping vouchers, pet accessories and much, much more! Pet owners will be able to submit photos, videos and stories to http://www.mypetsuperstar.com/ which has four competition categories:
Dan White, Drontal product manager said: "My Pet Superstar aims to celebrate the unique traits and talents that make us love and take pride in our pets. Visitors to the website will be able to vote for their favourite entries and even post these to their Facebook and Twitter accounts. With four very different categories, this competition will be wide open to all dog and cat owners. Our motto is that healthy pets are happy pets, and we will use the competition to remind dog and cat owners about the benefits of regular worming.
Practices can get involved by displaying waiting room materials including A4 static window posters, shelf wobblers and mobile hanging devices by calling 0845 257 4798.
Alternative remedies which could be dangerous to pets are being targeted by the Government in a major drive to improve animal health and welfare. Some herbal and homeopathic products are claiming medicinal benefits without scientific proof, meaning they may not properly treat or prevent serious diseases, leaving pets at risk.
The Veterinary Medicines Directorate’s (VMD) Director of Operations, John FitzGerald, said: "Some of these products are claiming to be effective and safe when no scientific evidence has been presented to us to show they are.
"Animal owners have a right to know if a product does what it claims. The products claim to treat diseases which can cause serious welfare problems and in some circumstances kill animals if not properly treated. So in some cases owners are giving remedies to their pets which don’t treat the problem."
A number of unauthorised products are being targeted, including:
From now on, the VMD will be contacting manufacturers to ensure that they demonstrate the products are safe and provide the benefits which they claim to. If this is not the case the manufacturers will be required to re-brand the products to make it clear they are not medicinal.
Supporting the action, British Veterinary Association President Harvey Locke said: "As veterinary surgeons we rely on the use of safe, effective and quality medicines for the health and welfare of animals under our care – and there must always be sound scientific evidence to back up medicinal claims made by the manufacturer of any product.
"Some of these unauthorised products may at the least be ineffective and at worst could cause harm because serious life-threatening diseases may go undiagnosed. We would urge animal owners always to check with their veterinary surgeon before giving any remedy or supplement to their pet."
Dechra Veterinary Products has launched a case study competition to find out how veterinary professionals are using Celox, its new haemostatic agent designed to stop heavy bleeding.
According to the company, Celox Veterinary forms a gel-like clot within 30 seconds when mixed with blood.
Dechra says it would like examples of how it has been used, whether for planned procedures or in an emergency, and is asking veterinary surgeons and nurses to send in case histories and photos for the chance to win an iPad2.
Rachel Horton, Dechra's Brand Manager for Woundcare, said: "Celox Veterinary was launched to the market last year, with the human version of the product being used with great success on the battlefield by the British military for several years.
"Now we are asking veterinary professionals to share their experiences of using Celox Veterinary in practice, whether used in its gauze or granular form. It is ideal for fast-acting haemostasis, and provides a quick and efficient solution wherever and whenever bleeding needs to be stopped fast.
"Entrants providing case histories with accompanying photos can enter as many times as they like and have a chance to win an iPad2. Learning about how veterinary professionals are using products is important to Dechra Veterinary Products and assists in developing the high level of support we offer to vets and vet nurses."
Dechra says Celox Veterinary is being used not only for trauma injuries and emergency first aid but also for planned operations including castration, mass removal, nasal polyps, dental extractions and soft palate resections.
Case histories should be emailed to Rachel.Horton@dechra.com before the closing date of July 20th 2012 to be eligible for the draw. For further information about Celox Veterinary, please visit see www.dechra.com
VRCC veterinary referral centre, the leading European veterinary cancer treatment centre, has announced that it has installed what is believed to be the first and only new 'Human' CT scanner in a UK private small animal veterinary centre, at a cost of nearly £500,000. The announcement came less than a year after the centre's 6 million volt linear accelerator went online - currently the only veterinary radiotherapy facility in the UK. Apart from routine scans required by all the clinicians at the centre, VRCC also takes referrals in medicine, surgery and oncology. Its CT will also be used in conjunction with the linear accelerator, offering sophisticated cancer treatments previously not available in the UK. In another first for VRCC, the centre has appointed Tom Jackson BSc Radiography (T), a therapeutic radiographer from Guys & St Thomas Westminster, a centre of excellence in oncology. Tom will be working under the direction of the centre's clinical director, Dr Susan North, the most highly qualified and experienced veterinary oncologist in the UK and the only qualified radiation veterinary oncologist in the UK.
For more information about the referral services available from VRCC, visit http://www.vrcc.co.uk/, or ring 01268 564664.
Diverse Undertakings Ltd. has announced that it is extending its services to include support for veterinary practices in securing their RCVS Practice Standards Scheme (PSS) accreditation.
The company was originally formed to provide business advisory services to small and medium sized enterprises across a range of industry sectors. Its services range from general H.R. advice, health & safety guidance and facilities management to candidate sourcing and call-centre services.
However, with previous experience supporting a substantial veterinary practice in Kent for both employment challenges and PSS accreditation, Company Director Neal Palk decided to extend the company's capability to support other veterinary practices in securing their PSS accreditation.
He says that because the needs of each practice vary, Diverse can adapt its service to reflect both the individual circumstances relating to accreditation as well as the capability/capacity with the practice to undertake necessary tasks itself. By using a network of associates, he says Diverse can call upon other specialities (for example - competitively priced office/building equipment) to smooth the progress to accreditation.
Diverse says it offers a range of transparent pricing options to suit the client which, without the overheads of large consultancies, often result in PSS accreditation being achieved for less cost than a typical administrative temp for a month. Monthly retention fee alternatives for other services are available, beginning at £95+ VAT.
Neal said: "Several organisations offer professional services to the veterinary practice sector, but few can claim to have 'been there, done that' and really understand the climate and culture the sector operates within. Diverse Undertakings Ltd. values its experience in the sector and aims to work with other practices to achieve both accreditation and wider business success."
For more details please contact Neal on 07771 843719, e-mail: info@diverseundertakings.com, or visit: http://www/diverseundertakings.com
Canterbury-based solicitor Cooper & Co, which specialises in dog law, has launched a series of CPD-qualifying webinars for veterinary professionals available at www.doglaw.tv.
The webinars, which are presented by Trevor Cooper, cover a wide variety of subjects, including:
In addition, the site hosts videos about dog behaviour by the well-known dog trainer and behaviourist Carolyn Menteith. The topics covered in her videos include:
Whilst the videos are CPD-qualifying for veterinary professionals, they are also aimed at anyone else that works with dogs, and dog owners themselves.
To view the videos visit www.doglaw.tv.
The review coincided with a move last month from RUMA, the agricultural and food industry alliance which promotes responsible use of medicines in farm animals, to align with the EMA position.
The announcement means that under PVS guidelines, fluoroquinolones, 3rd and 4th generation cephalosporins and colistin will retain Class 3 status. This means they are only used when no other options are available and when supported by laboratory sensitivity testing – or exceptionally when all other options have failed.
Class 1 antibiotics form the standard prescribing list within responsible use guidelines and Class 2 are used only when sensitivity tests or clinical experience proves standard antibiotics are not effective. In all treatment decisions the health and welfare of the pigs must always take priority.
Betalactams with betalactamase inhibitors (clavulanic acid) were previously in the highest priority Class 3 but in light of the list defined by the EMA, which has been adopted by the Veterinary Medicines Directorate as well as RUMA, the PVS has reassessed the risk and moved them to Class 2 to align them with plain betalactams. This means they are still subject to voluntary restrictions, but their use would not necessarily be only as a last resort.
PVS president Mark White said that despite the ongoing review process and the potential to reclassify certain products, the Society’s underlying principles remain unchanged: "The total amount of all antibiotics used on pig farms to treat and prevent disease should be minimised, and the types of antibiotics used in pigs should be considered in light of the implications for antibiotic resistance challenges in both pigs and man.
"This policy is proving successful with AHDB Pork’s electronic pig medicine book (e-MB) recently showing that use of colistin appears to have fallen by over 70% in 2016 following its move to a Class 3 antibiotic in late 2015.
"We must also continue to be alert to the possibility of cross resistance, even in older antibiotics that have little or no use in humans. Risk must be acknowledged where it exists and overall reductions are still imperative."
RUMA has welcomed the review and alignment from the PVS. Secretary General John FitzGerald said: "Farmers and vets need boundaries within which to operate and clear objectives to meet, and we would urge all supply chains, from farmer to retailer, to align with the sector position on best practice use of antibiotics, as defined by each sector’s professional veterinary organisation."
The meeting will be led by Dr Rosanne Jepson BVSc MVetMed PhD DipACVIM DipECVIM PGCertVetEd FHEA MRCVS, Associate Professor Small Animal Internal Medicine Specialist at the RVC. It will consist of two talks.
The first, ‘Hypertension and concurrent diseases’, will cover how veterinary surgeons should manage and treat hypertension when it presents with other concurrent diseases such as CKD and hyperthyroidism.
The second, ‘Overview of diagnosis and stage specific management of feline CKD’, will review the recently updated IRIS guidelines and discuss the latest and most up-to-date methods in diagnosing and managing CKD in both the early and later stages.
The meeting will account for two hours CPD.
To register for the CPD meeting, contact your local Ceva account manager or email your name, practice name and telephone number to cevauk@ceva.com.
Biogal has announced the launch of the PCRun Molecular Detection Kit, designed to give PCR results in clinic or in the lab within an hour.
The new kit doesn't require any other equipment, such as a thermocycler.
PCRun is a molecular assay based on the isothermal amplification of part of the HapI gene. The company says it is intended for the qualitative detection of pathogenic species of Leptospires only.
The PCRun has been tested at the OEI Leptospira Reference Laboratory in Ireland, on sample materials including urine and kidney biopsies collected from cows experimentally infected with L. hardjo as well as kidney cells.
According to the company, no false positive results were observed in all 63 samples tested and there was excellent correlation between Real Time PCR and PCRun reactions.
Results of the study and a list of serovars tested with PCRun are available from Biogal. See: http://www.biogal.co.il/products/pcrun
The merger brings together Improve International’s global reach and postgraduate qualification programmes with Central CPD’s practitioner-led Continuing Professional Development training and digital learning infrastructure.
Improve says the merger will better position the two companies to meet the growing and evolving needs of the profession.
However, the veterinary training marketplace has been hit recently by news that IVC Evidensia has opened two in-house training centres, one in Scotland and one in the Midlands, perhaps precipitating some consolidation, especially since IVC has announced plans to offer CPD to the wider profession later this year.
Researchers at the Royal Veterinary College (RVC) have developed a system that eliminates the need for antibiotics and resistance genes in the engineering of industrial and medical products.
The method involves safer, less costly alternatives and is well suited for industrial production of many biofuels and biopharmaceuticals. This research has been published in the online access journal BMC Biotechnology.
Genetic engineering underpins much of biotechnology, and antibiotic selection of engineered strains is a key tool. Unfortunately, antibiotic selection methods risk spreading resistance traits, particularly as biotechnology products move into the environment and clinic. There have been alternatives, but none are satisfactory for wide application.
Gene targeting is the insertion of DNA into specific sites or genes within the genome of selected cells in order to alter gene expression for a particular purpose.
While working on gene targeting in bacteria, RVC researchers discovered that a well-known interaction between a cell membrane synthesis gene and the biocide triclosan could be exploited for strain selection. Surprisingly, triclosan selection performs better than conventional antibiotic selection.
"We think this simple technology is well suited for industrial scale fermentations that produce a range of valuable products, including bio-fuels and bio-pharmaceuticals," said Dr Liam Good, at the Royal Veterinary College and lead researcher on the project. "More importantly, the new system is relatively safe and inexpensive, because the gene is native in all bacteria and triclosan is approved for use in many household applications."
The research was carried out with Dr Shan Goh of the Department of Cell and Molecular Biology, Karolinska Institute, Stockholm.
Merial has launched a 'Vaccination Back on Track' promotion via vet practices that administer Merial vaccines.
Under the scheme, owners of all horses over 12 months of age that have not yet been vaccinated against equine influenza or are overdue a booster obtain a primary vaccination course at an attractive discounted rate. A tetanus component is also available if required.
Dr Emma Batson from Merial said: "With continuing cases of equine flu recorded in the UK, and a global increase in the number of serious outbreaks, it has never been more important to ensure that horses are protected against this underestimated threat.
"It's often not fully understood that equine flu can be transferred indirectly via inanimate objects such as horse boxes, fencing or human clothing. With just 37% of horses in the UK estimated to be vaccinated, this leaves a significant naive and vulnerable population at risk".
Merial says there is no limit on the number of horses that can be vaccinated, making it a particularly attractive offer for those with more than one horse or yard(s).
Participating practices have the option to run the scheme in any month between now and December 2009. For information, contact your Merial Territory Manager.
The Kennel Club Genetics Centre at the AHT has identified a genetic mutation which causes a severe progressive disease in Parson Russell Terriers (PRTs).
Late onset ataxia (LOA) affects coordination and balance, making everyday movement and tasks increasingly difficult. The new DNA test can accurately predict the risk of developing the disease in 97-100 per cent of PRTs and will effectively reduce the number of LOA cases in the breed.
Dogs usually develop the disease between six months and one year of age but because there is no cure, sufferers are usually euthanised around two years after onset as their quality of life diminishes.
After testing DNA of over 200 PRTs in total, the AHT's scientists were able to isolate the genetic mutation which causes the disease and establish that LOA is an inherited recessive trait; therefore dogs must have two defective copies of the genetic mutation, one from each parent, to be affected.
The test results will inform dog owners if their dog is clear from, a carrier of, or affected by LOA.
Cathryn Mellersh, Head of Canine Genetics, at the AHT said: "This is great news for PRT breeders as we believe LOA is an emerging condition in the breed and through this test we should be able to cut the disorder 'off at the pass', before the mutation becomes any more widespread.
"Interestingly, our research also suggests that there may be other causes of ataxia in the breed. It is important for breeders to understand that a clear result using the LOA DNA test will not exclude the formal possibility that dogs could still develop a genetically different form of ataxia."
Caroline Kisko, Kennel Club Secretary, said: "LOA is a relatively new but devastating condition and we are delighted that we've been able to work with the Animal Health Trust to develop a DNA test that will give breeders the opportunity to significantly reduce this disease. We will keep working together to develop tools and information for breeders, so that they are able to select dogs that will have healthy puppies."
The DNA test for LOA is available from the AHT at the price of £48. Full details are available at www.ahtdnatesting.co.uk.
Virbac is offering its customers a discount on subscriptions to Vet Care Consult, an interactive veterinary medicine and anatomy tool designed to improve client understanding and aid compliance.
Vet Care Consult, designed by MediProductions with advice from veterinary specialists, uses more than 600 3D graphics, animations, videos and other imagery to help veterinary staff explain diagnoses and to discuss therapeutic options.
The veterinary surgeon or nurse selects the target species, then the relevant organ or system. A range of animations and videos are then offered to help explain their recommendation. The tool includes the option to email owners a link to a specific animation or video so that they can discuss the recommended treatment with family later. It can be used on a PC or tablet and is also available as an iPhone app.
A single user subscription normally costs £41 per month or £410 per annum.
Chris Geddes MRCVS, Senior Product Manager at Virbac, said: "Gone are the days of scribbling diagrams on scraps of paper and whiteboards or pointing to a model of a stifle that has seen better days!
"Vet Care Consult harnesses the latest technology to help the veterinary team communicate more effectively with clients, helping them to understand their pets' health and wellness issues. Better communication leads to improved compliance which, in turn, helps to strengthen the vital bond between a practice and its clients."
For more information, contact your Virbac Territory Manager.